PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34986718-5	2022	Other tested B-Raf inhibitors, both type-I (dabrafenib and encorafenib) and type-II (RAF265 and AZ628), also exhibited potent therapeutic effects on SM-exposed HaCaT cells.	Mustard Gas	149-151	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	13-18